A generic drug manufacturer from Iceland will spend $14 million to expand its pharmaceuticals plant in Lincolnton while adding about 50 jobs. For Actavis Group, the world's third-largest maker of generic drugs, the expansion will be the second addition to the plant in a year. In September 2005, the facility in Indian Creek Industrial Park -- then owned by Alpharma Inc. -- underwent a $7 million to expansion.
